Immunotherapy in acute myeloid leukemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|16|2689-2704

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.16, 2015-08, pp. : 2689-2704

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotherapy with histamine dihydrochloride and low‐dose interleukin‐2 favors sustained lymphocyte recovery in acute myeloid leukemia

By  

EUROPEAN JOURNAL OF HAEMATOLOGY, Vol. 94, Iss. 3, 2015-03 ,pp. : 279-280

John Wiley & Sons Inc

Access to resources Recommend Favorite

The denominator variable in the quantitation of MRD in acute myeloid leukemia

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 11, 2015-11 ,pp. : E213-E215

John Wiley & Sons Inc

Access to resources Recommend Favorite

“Epigenetic” modification as therapy for acute myeloid leukemia

By  

CANCER, Vol. 124, Iss. 2, 2018-01 ,pp. : 242-244

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiogenesis in Acute Myeloid Leukemia and Myelodysplastic Syndrome

By  

Acta Haematologica, Vol. 106, Iss. 4, 2002-01 ,pp. : 170-176

Karger

Access to resources Recommend Favorite

Acute Myeloid Leukemia Unlikely Related to Trabectedin Treatment

By  

Acta Haematologica, Vol. 126, Iss. 4, 2011-09 ,pp. : 238-239

Karger

Access to resources Recommend Favorite